References

  1. Lemogoum D, Degaute JP, Bovet P. Stroke prevention, treatment and rehabilitation in sub-saharan Africa. Am J Prev Med. 2005; 29(5 Suppl 1): 95-101. PubMed | Google Scholar

  2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997; 349(9061): 1269-76. PubMed | Google Scholar

  3. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the oxfordshire community stroke project. Stroke. 1993; 24(6): 796-800. PubMed

  4. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs and effects on individuals and populations. Lancet. 1999; 354(9188): 1457-63. PubMed | Google Scholar

  5. Heller RF, Langhorne P, James E. Improving stroke outcome: the benefits of increasing availability of technology. Bull World Health Organ. 2000; 78(11): 1337-43. PubMed | Google Scholar

  6. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP et al. The Harvard cooperative stroke registry: a prospective registry. Neurology. 1978; 28(8): 754-62. PubMed | Google Scholar

  7. Sandercock P, Bamford J, Dennis M, Bum J, Slattery J, Jones L et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). Br Med J. 1992; 305(6867): 1460-5. PubMed | Google Scholar

  8. Hohnloser SH, Crijns HJ, Van Eickels M, Gaudin C, Page RL, Torp-Pedersen C et al. Effect of dronaderone on cardiovascular events in atrial fibrillation. N Engl J Med. 2009; 360(7): 668-78. PubMed | Google Scholar

  9. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12): 1139-51. PubMed | Google Scholar

  10. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the framigham study. Arch Intern Med. 1987; 147(9): 1561-4. PubMed | Google Scholar

  11. Rizos T, Rasch C, Jenetzky E, Hametner C, Kathoefer S, Reinhardt R et al. Dectection of paroxysmal atrial fibrillation in acute stroke patients. Cerebrovasc Dis. 2010; 30(4): 410-17. PubMed | Google Scholar

  12. Alhadramy O, Jeerakathil TJ, Majumdar SR, Najjar E, Choy J, Saqqur M. Prevalence and predictors of paroxysmal atrial fibrillation on holter monitor in patients with stroke or transient ischemic attack. Stroke. 2010; 41(11): 2596-600. PubMed

  13. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel. Usefulness of ambulatory 7-Day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004; 35(7): 1647-51. PubMed

  14. Barthélémy JC, Féasson-Gérard S, Garnier P, Gaspoz JM, Da Costa A, Michel D et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol. 2003; 8(3): 194-9. PubMed | Google Scholar

  15. Gunalp M, Atalar E, Coskun F, Yilmaz A, Aksoyek S, Aksu NM et al. Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department. Adv Ther. 2006; 23(6): 854-60. PubMed | Google Scholar

  16. Gombet TR, Ellenga Mbolla, Ikama MS, Etitiele F. Facteurs de risque des accidents vasculaires cérébraux ischémiques au Centre Hospitalier et Universitaire de Brazzaville. Med Afr Noire. 2007; 54(12): 629-45.

  17. Mapoure NY, Tchaleu Nguenkam CB, Mbatchou Ngahane HB, Dzudie A, Coulibaly A, Mounjouopou NG et al. Predictors of in-hospital mortality for stroke in Douala, Cameroon. Stroke Res Treat. 2014; 2014: 681209. PubMed | Google Scholar

  18. Hornig CR, Haberbosh W, Lammers C, Waldecker B, Dorndorf W. Specific cardiological evaluation after focal cerebral ischemia. Acta Neurol Scand. 1996; 93(4): 297-302. PubMed | Google Scholar

  19. Schaer BA, Zellweger MJ, Cron TA, Kaiser CA, Osswald S. Value of routine holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke. 2004; 35(3): e68-e70. PubMed

  20. Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis. 2009; 18(3): 185-9. PubMed | Google Scholar

  21. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R et al. Continuous stroke unit electrocardiographic montoring Versus 24-Hour holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012; 43(10): 2689-94. PubMed

  22. Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013; 44(5): 1449-52. PubMed

  23. Wallmann D, Tüller D, Wusmann K, Meier P, Isenegger J, Arnold M et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke. 2007; 38(8): 2292-4. PubMed | Google Scholar

  24. Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008; 71(21): 1696-701. PubMed | Google Scholar

  25. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013; 80(17): 1546-50. PubMed | Google Scholar